CARISSA SHEPHERD: Open Payments
NPI 1083756829 · GREENTOWN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,054 in 71 payments from 13 companies in 2025. Trend: 2023 $832 · 2024 $1,201 · 2025 $1,054
Food & beverage: $1,054
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $274 |
| Novo Nordisk Inc | 25 | $253 |
| AstraZeneca Pharmaceuticals LP | 7 | $180 |
| Lilly USA, LLC | 4 | $71 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| PFIZER INC. | 3 | $53 |
| Dexcom, Inc. | 2 | $47 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 3 | $23 |
| Exact Sciences Corporation | 1 | $20 |
Products named: Ozempic, Wegovy, VRAYLAR, QULIPTA, AIRSUPRA, FARXIGA, MOUNJARO, Auvelity.
Industry payments across IN — which companies pay providers there.
